Form D · Hedge Fund

First Eagle Value in Biotechnology Fund (QP), LP

New York, NY · CIK 0001481559

Offering snapshot reported Mar 13, 2018 · SEC filing

Reported sold
$68.2M
Indefinite offering
Investors reported
65
Form D · investor count
Minimum accepted
$1M
Reported outside-investor minimum
First sale
Sep 15, 2005
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$34.1M$68.2MMar 10, 2010: $45,000,000.00Mar 10, 2010Mar 10, 2011: $47,950,000.00Mar 12, 2012: $48,450,000.00Mar 12, 2013: $48,700,000.00Mar 12, 2014: $52,700,000.00Mar 12, 2015: $52,700,000.00Mar 14, 2016: $52,700,000.00Mar 13, 2017: $68,150,000.00Mar 13, 2018: $68,150,000.00Mar 13, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 13, 2018Amendment$68,150,000$0vs Mar 13, 201765SEC filing
Mar 13, 2017Amendment$68,150,000$15,450,000vs Mar 14, 201665SEC filing
Mar 14, 2016Amendment$52,700,000$0vs Mar 12, 201565SEC filing
Mar 12, 2015Amendment$52,700,000$0vs Mar 12, 201465SEC filing
Mar 12, 2014Amendment$52,700,000$4,000,000vs Mar 12, 201365SEC filing
Mar 12, 2013Amendment$48,700,000$250,000vs Mar 12, 201264SEC filing
Mar 12, 2012Amendment$48,450,000$500,000vs Mar 10, 201163SEC filing
Mar 10, 2011Amendment$47,950,000$2,950,000vs Mar 10, 201063SEC filing
Mar 10, 2010Initial$45,000,000No comparison63SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.1
Duration over one year
Yes
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-139441

Source: Form D, filed Mar 13, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

FIRST EAGLE VALUE IN BIOTECHNOLOGY MASTER FUND, LTD.

Investment adviser: FIRST EAGLE INVESTMENT MANAGEMENT, LLC

Gross asset value
$24.1M
Beneficial owners
2
ADV minimum commitment
$100K

Reported in Form ADV on Aug 2, 2019. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator MORGAN STANLEY FUND SERVICES (BERMUDA) LTD. HAMILTON, Bermuda Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor RSM US LLP CHICAGO, Illinois, United States
Custodian MERRILL LYNCH PROFESSIONAL CLEARING CORP. NEW YORK, New York, United States Related to adviser: No
Custodian THE NORTHERN TRUST INTERNATIONAL BANKING CORPORATION JERSEY CITY, New Jersey, United States Related to adviser: No
Marketer FEF DISTRIBUTORS, LLC NEW YORK, New York, United States Related to adviser: Yes
Prime broker MERRILL LYNCH PROFESSIONAL CLEARING CORP. NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
Yes

RSM US LLP
PCAOB 49

MERRILL LYNCH PROFESSIONAL CLEARING CORP.
SEC 8-33359

FEF DISTRIBUTORS, LLC
CRD 46585 · SEC 8-51483

MERRILL LYNCH PROFESSIONAL CLEARING CORP.
CRD 16139 · SEC 8-33359

Filing source

Form ADV 1337981 · Aug 2, 2019 · Schedule D 7.B.(1), fund 805-5286184337

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
First Eagle Investment Management, Llc Executive
Tim Tabor Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
First Eagle Investment Management, Llc 1345 Avenue Of The Americas, 48 Th Floor
New York, NY, 10105